Final Guidance: Reformulating Drug Products That Contain Carbomers Manufactured With Benzene-2023/12/27

Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)-2025/1/31

Document: Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations-2025/2/27

Document: Highlight report - 13th Industry stakeholder platform on research and development support-2025/4/4

Document: HMPC: overview of assessment work - priority list-2025/5/15

2025年6月25日中药品种保护受理公示-2025/6/25

Document: Template for scientific document for paediatric investigation plan or product-specific waiver-2025/7/28

关于公开征求《艾滋病免疫功能重建不全治疗药物临床试验技术指导原则（征求意见稿）》意见的通知-2025/9/12

Document: Process for the electronic submission of medicinal product information - Chapter 3-2025/10/16

国家药监局关于发布药品生产企业出口药品检查和出口证明管理规定的公告（2025年第113号）-2025/11/21